Univar (UNVR) Prices 20.9M Share Secondary Offering
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Univar Inc. (NYSE: UNVR) announced the pricing of the previously announced public offering of 20,943,741 shares of Univar's common stock (representing approximately 15.2% of its issued and outstanding shares) by Univar N.V. and GSO COF Facility LLC (the "Selling Stockholders") to Goldman, Sachs & Co., as the sole underwriter in the registered public offering of those shares, at a price to the public of $19.00 per share. Univar N.V. holds shares the economic benefit of which are held by investment funds affiliated with CVC Capital Partners Advisory (U.S.) Inc. ("CVC"), investment funds affiliated with Parcom ("Parcom") and certain current and former members of management. The shares sold by Univar N.V. represent the economic interest of CVC and certain current and former members of management of Univar. Parcom will not sell any of its economic interest in Univar in this offering. The offering is expected to close and settle on August 18, 2016. The Selling Stockholders will receive all of the net proceeds from this offering. No shares are being sold by Univar. Following the offering, Univar N.V. will own 3,785,855 shares of Univar's common stock and all of these shares will be beneficially owned by Parcom. Following the offering, GSO COF Facility LLC will own no shares of Univar's common stock.
A shelf registration statement (including a prospectus) for the offering to which this communication relates has previously been filed with the U.S. Securities and Exchange Commission and has become effective. Before you invest, you should read the prospectus in that registration statement and other documents Univar has filed with the SEC for more complete information about Univar and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, copies of the prospectus and prospectus supplement, when available, may be obtained from Goldman, Sachs & Co., Prospectus Department, 200 West Street, New York, NY 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing email@example.com.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Herbalife (HLF) Provides Q4, FY17 Guidance in Memorandum for $1.325B Credit Facility; Lowers FY17 Sales Guidance
- Amedica (AMDA) Prices $4.5M Offering of Common Stock and Warrants
- Amedica (AMDA) Plans Offering of Common Stock and Warrants
Create E-mail Alert Related CategoriesCorporate News, Equity Offerings
Related EntitiesCVC Capital Partners
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!